WKY/Izm |
cell membrane potential |
control condition |
Iigaya K, et al., Hypertension. 2008 Dec 1. |
action potential trait |
not specified |
0 days-4 days |
8 |
|
-57.0 |
mV |
0.35 |
1.0 |
whole-cell patch clamp technique |
|
600 |
0 |
|
irregularly firing neurons |
65897 |
634 |
WKY/Izm |
body weight |
controlled fat content diet (5 %) (for 70 days) and controlled potassium content diet (0.75 %) (for 70 days) then controlled fat content diet (26 %) (for 14 days) and controlled potassium content diet (0.44 %) (for 14 days) |
Watanabe T, et al., Biochem Biophys Res Commun 2005 Apr 15;329(3):879-87. |
body mass |
male |
119 days
| 10 |
|
325.0 |
g |
5.34 |
16.9 |
body weighing method |
|
|
0 |
|
|
12491 |
263 |
WKY/Izm |
serum total cholesterol level |
fasting (0 null) (for 16 hours) |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
blood cholesterol amount |
male |
91 days
| 5 |
|
75.68 |
mg/dl |
3.09 |
6.91 |
serum total cholesterol measurement test |
|
0 |
0 |
|
|
64852 |
115 |
WKY/Izm |
serum triglyceride level |
fasting (0 null) (for 16 hours) |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
blood triglyceride amount |
male |
91 days
| 5 |
|
24.78 |
mg/dl |
2.65 |
5.94 |
serum triglyceride analysis |
|
0 |
0 |
|
|
64858 |
115 |
WKY/Izm |
urine vanillylmandelic acid excretion rate |
cold ambient air exposure (4 degrees C) (for 4 hours) |
Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. |
urine vanillylmandelic acid amount |
not specified |
0 days
| 14 |
|
1650.0 |
pmol/4h |
125.61 |
470.0 |
high-performance liquid chromatography |
|
0.0 |
0 |
hplc |
urine vanillylmandelic acid exretion rate |
68663 |
971 |
WKY/Izm |
body weight |
specific pathogen-free condition |
NBRP Body Weight data |
body mass |
male |
35 days
| 6 |
|
101.2 |
g |
1.55 |
3.8 |
whole body digital scale |
|
|
0 |
|
|
70931 |
21 |
WKY/Izm |
body weight |
specific pathogen-free condition |
NBRP Body Weight data |
body mass |
male |
70 days
| 6 |
|
285.9 |
g |
3.63 |
8.9 |
whole body digital scale |
|
|
0 |
|
|
70932 |
21 |
WKY/Izm |
adipocyte maximal glucose uptake |
controlled fat content diet (5 %) (for 70 days) and controlled potassium content diet (0.75 %) (for 70 days) then insulin (50000 pmol/l) (for 1 hours) |
Watanabe T, et al., Biochem Biophys Res Commun 2005 Apr 15;329(3):879-87. |
adipocyte glucose uptake trait |
male |
105 days
| 10 |
|
144.5 |
x 1000 cpm/cell |
3.48 |
11.0 |
radioactive glucose uptake assay with liquid scintillation counting |
|
0.0 |
0 |
|
|
67928 |
263 |
WKY/Izm |
absolute change in mean arterial blood pressure |
air-jet exposure (for 0 hours) then hexamethonium (40 mg/kg) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
arterial blood pressure trait |
male |
98 days
| 6 |
|
-49.0 |
mmHg |
5.0 |
12.25 |
vascular indwelling catheter method |
|
0.0 |
0 |
|
|
69089 |
1120 |
WKY/Izm |
serum free fatty acids level |
controlled fat content diet (5 %) (for 70 days) and controlled potassium content diet (0.75 %) (for 70 days) then fasting (for 16 hours) |
Watanabe T, et al., Biochem Biophys Res Commun 2005 Apr 15;329(3):879-87. |
blood free fatty acid amount |
male |
98 days
| 10 |
|
0.02 |
mmol/l |
0.0 |
0.0 |
serum free fatty acid analysis |
|
0.0 |
0 |
|
|
67923 |
263 |
WKY/Izm |
absolute change in systolic blood pressure |
room temperature (for 0.5 hours) then cold ambient air exposure (4 degrees C) (for 4 hours) |
Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. |
arterial blood pressure trait |
not specified |
84 days-112 days |
6 |
serial mean |
19.0 |
mmHg |
0.82 |
2.0 |
radiotelemetry |
|
16200.0 |
0 |
10 s every 5 min |
|
68682 |
971 |
WKY/Izm |
absolute change in diastolic blood pressure |
room temperature (for 0.5 hours) then cold ambient air exposure (4 degrees C) (for 4 hours) |
Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. |
arterial blood pressure trait |
not specified |
84 days-112 days |
6 |
serial mean |
17.0 |
mmHg |
0.82 |
2.0 |
radiotelemetry |
|
16200.0 |
0 |
10 s every 5 min |
|
68684 |
971 |
WKY/Izm |
absolute change in systolic blood pressure |
physical restraint in mechanical restrainer (for 3 hours) |
Xiao B, et al., J Hypertens. 2010 Nov 8. |
arterial blood pressure trait |
male |
94 days
| 6 |
serial mean |
3.0 |
mmHg |
|
|
radiotelemetry |
|
0.0 |
0 |
|
avg of 5 measurements for |
84610 |
990 |
WKY/Izm |
mean corpuscular hemoglobin |
fasting (for 16 hours) |
NBRP Hematology & Blood Biochemistry data |
blood hemoglobin amount |
male |
70 days
| 6 |
|
19.2 |
pg |
0.08 |
0.2 |
automated cell/particle size/count analysis method |
|
|
0 |
Sysmex, F-800 type |
|
79840 |
1498 |
WKY/Izm |
white blood cell count |
fasting (for 16 hours) |
NBRP Hematology & Blood Biochemistry data |
leukocyte quantity |
male |
70 days
| 6 |
|
6.0 |
x 1000 cells/ul |
0.2 |
0.5 |
automated cell/particle size/count analysis method |
|
|
0 |
Sysmex, F-800 type |
|
79842 |
1498 |
WKY/Izm |
plasma chloride level |
fasting (for 16 hours) |
NBRP Hematology & Blood Biochemistry data |
blood chloride amount |
male |
70 days
| 6 |
|
106.0 |
mmol/l |
0.41 |
1.0 |
automated blood electrolyte analysis |
|
|
0 |
Analytical intruments, PVA alpha II |
|
79862 |
1498 |
WKY/Izm |
absolute change in mean arterial blood pressure |
air-jet exposure (for 0 hours) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
arterial blood pressure trait |
male |
98 days
| 6 |
|
22.0 |
mmHg |
2.0 |
4.9 |
vascular indwelling catheter method |
|
0.0 |
0 |
|
|
84537 |
1120 |
WKY/Izm |
systolic blood pressure |
control condition |
Xiao B, et al., J Hypertens. 2010 Nov 8. |
arterial blood pressure trait |
male |
84 days
| 16 |
serial mean |
118.0 |
mmHg |
|
|
tail cuff plethysmography |
|
0.0 |
0 |
|
avg of 5 measurements for |
84607 |
990 |
WKY/Izm |
absolute change in mean arterial blood pressure |
air-jet exposure (for 0 hours) then vehicle control condition (2 ul) (for 0 hours) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
arterial blood pressure trait |
male |
98 days
| 6 |
|
-3.0 |
mmHg |
2.0 |
4.9 |
vascular indwelling catheter method |
|
0.0 |
0 |
|
|
84553 |
1120 |
WKY/Izm |
heart wet weight |
specific pathogen-free condition |
NBRP Organ Weight data |
heart mass |
male |
70 days
| 6 |
|
0.95 |
g |
0.01 |
0.03 |
Shimadzu electronic balance post excision weight measurement |
|
|
0 |
|
|
72875 |
41 |
WKY/Izm |
both kidneys wet weight as percentage of body weight |
specific pathogen-free condition |
NBRP Organ Weight data |
kidney mass |
male |
70 days
| 6 |
|
0.67 |
% |
0.01 |
0.02 |
Shimadzu electronic balance post excision weight measurement |
|
|
0 |
|
|
72882 |
41 |
WKY/Izm |
both adrenal glands wet weight |
specific pathogen-free condition |
NBRP Organ Weight data |
adrenal gland mass |
male |
70 days
| 6 |
|
57.2 |
mg |
1.71 |
4.2 |
Shimadzu electronic balance post excision weight measurement |
|
|
0 |
|
|
72883 |
41 |
WKY/Izm |
systolic blood pressure |
control condition |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
arterial blood pressure trait |
female |
91 days
| 5 |
|
127.0 |
mmHg |
5.0 |
11.18 |
tail cuff plethysmography |
|
0 |
0 |
|
|
11683 |
115 |
WKY/Izm |
absolute change in adipocyte glucose uptake |
controlled fat content diet (5 %) (for 70 days) and controlled potassium content diet (0.75 %) (for 70 days) then insulin (50000 pmol/l) (for 1 hours) |
Watanabe T, et al., Biochem Biophys Res Commun 2005 Apr 15;329(3):879-87. |
adipocyte glucose uptake trait |
male |
105 days
| 10 |
|
106.6 |
cpm x 1000/cell |
4.33 |
13.7 |
radioactive glucose uptake assay with liquid scintillation counting |
|
0.0 |
0 |
|
|
67932 |
263 |
WKY/Izm |
mean corpuscular volume |
fasting (for 16 hours) |
NBRP Hematology & Blood Biochemistry data |
erythrocyte size trait |
male |
70 days
| 6 |
|
56.3 |
fl |
0.41 |
1.0 |
automated cell/particle size/count analysis method |
|
|
0 |
Sysmex, F-800 type |
|
79839 |
1498 |
WKY/Izm |
mean corpuscular hemoglobin concentration |
fasting (for 16 hours) |
NBRP Hematology & Blood Biochemistry data |
blood hemoglobin amount |
male |
70 days
| 6 |
|
34.1 |
g/dl |
0.29 |
0.7 |
automated cell/particle size/count analysis method |
|
|
0 |
Sysmex, F-800 type |
|
79841 |
1498 |
WKY/Izm |
blood basophil count to total leukocyte count ratio |
fasting (for 16 hours) |
NBRP Hematology & Blood Biochemistry data |
basophil quantity |
male |
70 days
| 6 |
|
0.0 |
% |
0.0 |
0.0 |
automated differential white blood cell count test |
|
|
0 |
May-Giemsa staining |
|
79863 |
1498 |
WKY/Izm |
blood monocyte count to total leukocyte count ratio |
fasting (for 16 hours) |
NBRP Hematology & Blood Biochemistry data |
monocyte quantity |
male |
70 days
| 6 |
|
0.0 |
% |
0.41 |
1.0 |
automated differential white blood cell count test |
|
|
0 |
May-Giemsa staining |
|
79868 |
1498 |
WKY/Izm |
brain wet weight |
specific pathogen-free condition |
NBRP Organ Weight data |
brain mass |
male |
70 days
| 6 |
|
2.14 |
g |
0.02 |
0.04 |
Shimadzu electronic balance post excision weight measurement |
|
|
0 |
|
|
72873 |
41 |
WKY/Izm |
absolute change in mean arterial blood pressure |
vehicle control condition (2 ul) (for 0 hours) then air-jet exposure (for 0 hours) then angiotensin II (20 ng) then phenylephrine (3 ug) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
arterial blood pressure trait |
male |
98 days
| 6 |
|
50.0 |
mmHg |
2.0 |
4.9 |
vascular indwelling catheter method |
|
0.0 |
0 |
|
|
84570 |
1120 |
WKY/Izm |
absolute change in heart rate |
air-jet exposure (for 0 hours) then vehicle control condition (2 ul) (for 0 hours) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
heart pumping trait |
male |
98 days
| 6 |
|
0.0 |
beats/min |
6.0 |
14.7 |
vascular indwelling catheter method |
|
0.0 |
0 |
|
|
84562 |
1120 |
WKY/Izm |
cell membrane potential |
control condition |
Iigaya K, et al., Hypertension. 2008 Dec 1. |
action potential trait |
not specified |
0 days-4 days |
7 |
|
-55.4 |
mV |
2.12 |
5.6 |
whole-cell patch clamp technique |
|
600 |
0 |
|
regularly firing neurons |
65893 |
634 |
WKY/Izm |
systolic blood pressure |
control condition |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
arterial blood pressure trait |
male |
91 days
| 5 |
|
131.8 |
mmHg |
2.0 |
4.47 |
tail cuff plethysmography |
|
|
0 |
|
|
11679 |
115 |
WKY/Izm |
serum triglyceride level |
controlled fat content diet (5 %) (for 70 days) and controlled potassium content diet (0.75 %) (for 70 days) then fasting (for 16 hours) |
Watanabe T, et al., Biochem Biophys Res Commun 2005 Apr 15;329(3):879-87. |
blood triglyceride amount |
male |
98 days
| 10 |
|
11.0 |
mg/dl |
1.08 |
3.4 |
serum triglyceride analysis |
|
|
0 |
|
|
12499 |
263 |
WKY/Izm |
retroperitoneal fat pad weight to body weight ratio |
control condition (0 null) |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
retroperitoneal fat pad mass |
male |
91 days
| 5 |
|
1.17 |
% |
0.1 |
0.22 |
post excision weight measurement |
|
0 |
0 |
|
|
64844 |
115 |
WKY/Izm |
body weight |
control condition (0 null) |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
body mass |
male |
91 days
| 5 |
|
318.0 |
g |
5.9 |
13.19 |
body weighing method |
|
0 |
0 |
|
|
64830 |
115 |
WKY/Izm |
heart weight to body weight ratio |
control condition (0 null) |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
heart mass |
female |
91 days
| 5 |
|
2.76 |
g/kg |
0.09 |
0.2 |
post excision weight measurement |
|
0 |
0 |
|
|
64840 |
115 |
WKY/Izm |
urine vanillylmandelic acid excretion rate |
room temperature (for 4 hours) then cold ambient air exposure (4 degrees C) (for 4 hours) |
Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. |
urine vanillylmandelic acid amount |
not specified |
0 days
| 14 |
|
1080.0 |
pmol/4h |
160.36 |
600.0 |
high-performance liquid chromatography |
|
0.0 |
0 |
hplc |
absolute change in vanillylmandelic acid excretion rate |
68666 |
971 |
WKY/Izm |
adipocyte maximal glucose uptake to basal glucose uptake ratio |
controlled fat content diet (5 %) (for 70 days) and controlled potassium content diet (0.75 %) (for 70 days) then insulin (50000 pmol/l) (for 1 hours) |
Watanabe T, et al., Biochem Biophys Res Commun 2005 Apr 15;329(3):879-87. |
adipocyte glucose uptake trait |
male |
105 days
| 10 |
|
3.88 |
null |
0.21 |
0.65 |
radioactive glucose uptake assay with liquid scintillation counting |
|
0.0 |
0 |
|
|
67930 |
263 |
WKY/Izm |
absolute change in adipocyte free fatty acid secretion |
controlled fat content diet (5 %) (for 70 days) and controlled potassium content diet (0.75 %) (for 70 days) then isoproterenol (200 nmol/l) |
Watanabe T, et al., Biochem Biophys Res Commun 2005 Apr 15;329(3):879-87. |
adipocyte free fatty acid secretion trait |
male |
105 days
| 10 |
|
8.39 |
pmol/cell |
0.57 |
1.79 |
lipolysis assay measuring free fatty acid release |
|
0.0 |
0 |
|
|
67934 |
263 |
WKY/Izm |
blood hemoglobin level |
fasting (for 16 hours) |
NBRP Hematology & Blood Biochemistry data |
blood hemoglobin amount |
male |
70 days
| 6 |
|
16.1 |
g/dl |
0.2 |
0.5 |
automated cell/particle size/count analysis method |
|
|
0 |
Sysmex, F-800 type |
|
79837 |
1498 |
WKY/Izm |
non-specified leukocyte count to total leukocyte count ratio |
fasting (for 16 hours) |
NBRP Hematology & Blood Biochemistry data |
leukocyte quantity |
male |
70 days
| 6 |
|
0.0 |
% |
0.0 |
0.0 |
automated differential white blood cell count test |
|
|
0 |
May-Giemsa staining |
unidentified differential wbc |
79869 |
1498 |
WKY/Izm |
absolute change in heart rate |
air-jet exposure (for 0 hours) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
heart pumping trait |
male |
98 days
| 6 |
|
85.0 |
beats/min |
8.0 |
19.6 |
vascular indwelling catheter method |
|
0.0 |
0 |
|
|
84558 |
1120 |
WKY/Izm |
absolute change in mean arterial blood pressure |
vehicle control condition (2 ul) (for 0 hours) then air-jet exposure (for 0 hours) then angiotensin II (20 ng) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
arterial blood pressure trait |
male |
98 days
| 6 |
|
27.0 |
mmHg |
3.0 |
7.35 |
vascular indwelling catheter method |
|
0.0 |
0 |
|
|
84566 |
1120 |
WKY/Izm |
absolute change in mean arterial blood pressure |
candesartan (1 ug) (for 0 hours) then air-jet exposure (for 0 hours) then angiotensin II (20 ng) then phenylephrine (3 ug) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
arterial blood pressure trait |
male |
98 days
| 6 |
|
53.0 |
mmHg |
3.0 |
7.35 |
vascular indwelling catheter method |
|
0.0 |
0 |
|
|
84571 |
1120 |
WKY/Izm |
lung wet weight |
specific pathogen-free condition |
NBRP Organ Weight data |
lung mass |
male |
70 days
| 6 |
|
1.09 |
g |
0.02 |
0.05 |
Shimadzu electronic balance post excision weight measurement |
|
|
0 |
|
|
72877 |
41 |
WKY/Izm |
both testes wet weight |
specific pathogen-free condition |
NBRP Organ Weight data |
testis mass |
male |
70 days
| 6 |
|
2.89 |
g |
0.02 |
0.06 |
Shimadzu electronic balance post excision weight measurement |
|
|
0 |
|
|
72887 |
41 |
WKY/Izm |
serum triglyceride level |
controlled fat content diet (5 %) (for 70 days) and controlled potassium content diet (0.75 %) (for 70 days) then controlled fat content diet (26 %) (for 14 days) and controlled potassium content diet (0.44 %) (for 14 days) then fasting (for 16 hours) |
Watanabe T, et al., Biochem Biophys Res Commun 2005 Apr 15;329(3):879-87. |
blood triglyceride amount |
male |
113 days
| 10 |
|
15.0 |
mg/dl |
1.8 |
5.7 |
serum triglyceride analysis |
|
|
0 |
|
|
12508 |
263 |
WKY/Izm |
mean arterial blood pressure |
control condition |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
arterial blood pressure trait |
male |
98 days
| 6 |
|
108.0 |
mmHg |
3.0 |
7.35 |
vascular indwelling catheter method |
|
0.0 |
0 |
|
|
69083 |
1120 |
WKY/Izm |
heart rate |
control condition |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
heart pumping trait |
male |
98 days
| 6 |
|
317.0 |
beats/min |
14.0 |
34.29 |
vascular indwelling catheter method |
|
0.0 |
0 |
|
|
69086 |
1120 |
WKY/Izm |
plasma creatinine level |
fasting (for 16 hours) |
NBRP Hematology & Blood Biochemistry data |
blood creatinine amount |
male |
70 days
| 6 |
|
0.22 |
mg/dl |
0.0 |
0.01 |
automated plasma creatinine analysis |
|
|
0 |
Hitachi, model 7170 |
|
79857 |
1498 |
WKY/Izm |
serum free fatty acids level |
fasting (0 null) (for 16 hours) |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
blood free fatty acid amount |
female |
91 days
| 5 |
|
0.68 |
mmol/l |
0.12 |
0.27 |
serum free fatty acid analysis |
|
0 |
0 |
|
|
64867 |
115 |
WKY/Izm |
mean arterial blood pressure |
control condition |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
arterial blood pressure trait |
male |
98 days
| 6 |
|
106.0 |
mmHg |
3.0 |
7.35 |
vascular indwelling catheter method |
|
0.0 |
0 |
|
|
84546 |
1120 |
WKY/Izm |
body weight |
controlled fat content diet (5 %) (for 70 days) and controlled potassium content diet (0.75 %) (for 70 days) |
Watanabe T, et al., Biochem Biophys Res Commun 2005 Apr 15;329(3):879-87. |
body mass |
male |
91 days-98 days |
10 |
|
318.0 |
g |
3.76 |
11.9 |
body weighing method |
|
|
0 |
|
|
12430 |
263 |
WKY/Izm |
serum total cholesterol level |
controlled fat content diet (5 %) (for 70 days) and controlled potassium content diet (0.75 %) (for 70 days) then controlled fat content diet (26 %) (for 14 days) and controlled potassium content diet (0.44 %) (for 14 days) then fasting (for 16 hours) |
Watanabe T, et al., Biochem Biophys Res Commun 2005 Apr 15;329(3):879-87. |
blood cholesterol amount |
male |
119 days
| 10 |
|
60.4 |
mg/dl |
1.04 |
3.3 |
serum total cholesterol measurement test |
|
|
0 |
|
|
12504 |
263 |
WKY/Izm |
retroperitoneal fat pad weight to body weight ratio |
control condition (0 null) |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
retroperitoneal fat pad mass |
female |
91 days
| 5 |
|
1.07 |
% |
0.04 |
0.08 |
post excision weight measurement |
|
0 |
0 |
|
|
64847 |
115 |
WKY/Izm |
serum total cholesterol level |
fasting (0 null) (for 16 hours) |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
blood cholesterol amount |
female |
91 days
| 5 |
|
77.99 |
mg/dl |
1.16 |
2.59 |
serum total cholesterol measurement test |
|
0 |
0 |
|
|
64855 |
115 |
WKY/Izm |
absolute change in systolic blood pressure |
room temperature (for 0.5 hours) then cold ambient air exposure (4 degrees C) (for 4 hours) |
Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. |
arterial blood pressure trait |
not specified |
84 days-112 days |
5 |
serial mean |
35.0 |
mmHg |
3.58 |
8.0 |
radiotelemetry |
|
16200.0 |
0 |
10 s every 5 min |
|
68676 |
971 |
WKY/Izm |
absolute change in diastolic blood pressure |
room temperature (for 0.5 hours) then cold ambient air exposure (4 degrees C) (for 4 hours) |
Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. |
arterial blood pressure trait |
not specified |
84 days-112 days |
5 |
serial mean |
33.0 |
mmHg |
3.13 |
7.0 |
radiotelemetry |
|
16200.0 |
0 |
10 s every 5 min |
|
68679 |
971 |
WKY/Izm |
absolute change in electrocardiographic low frequency R-R spectral component to high frequency R-R spectral component ratio |
physical restraint in mechanical restrainer (for 3 hours) |
Xiao B, et al., J Hypertens. 2010 Nov 8. |
heart pumping trait |
male |
91 days
| 5 |
serial mean |
0.3 |
null |
|
|
wire electrode telemetric electrocardiography with power spectral analysis |
|
0.0 |
0 |
|
avg of 5 measurements for |
84609 |
990 |
WKY/Izm |
activated partial thromboplastin time |
fasting (for 16 hours) |
NBRP Hematology & Blood Biochemistry data |
blood coagulation trait |
male |
70 days
| 6 |
|
15.1 |
s |
0.2 |
0.5 |
automated coagulometer method |
|
|
0 |
Sysmex, CA-3000 type |
|
79845 |
1498 |
WKY/Izm |
plasma urea nitrogen level |
fasting (for 16 hours) |
NBRP Hematology & Blood Biochemistry data |
blood urea nitrogen amount |
male |
70 days
| 6 |
|
5.5 |
mmol/l |
0.25 |
0.61 |
automated plasma analysis |
|
|
0 |
PMID:15591307 |
|
79856 |
1498 |
WKY/Izm |
total plasma calcium level |
fasting (for 16 hours) |
NBRP Hematology & Blood Biochemistry data |
blood calcium amount |
male |
70 days
| 6 |
|
9.9 |
mg/dl |
0.04 |
0.1 |
automated blood electrolyte analysis |
|
|
0 |
Hitachi, model 7170 |
|
79859 |
1498 |
WKY/Izm |
heart rate |
control condition |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
heart pumping trait |
male |
98 days
| 6 |
|
306.0 |
beats/min |
12.0 |
29.39 |
vascular indwelling catheter method |
|
0.0 |
0 |
|
|
84549 |
1120 |
WKY/Izm |
urine chloride level |
0.9% sodium chloride solution (25 ml/kg) |
NBRP Urine Volume and Urine Electrolyte data |
urine chloride amount |
male |
63 days
| 6 |
|
152.0 |
mEq/L |
9.8 |
24.0 |
automated urine analysis |
|
|
0 |
|
|
95538 |
1662 |
WKY/Izm |
urine chloride excretion rate to body weight ratio |
0.9% sodium chloride solution (25 ml/kg) |
NBRP Urine Volume and Urine Electrolyte data |
urine chloride amount |
male |
63 days
| 6 |
|
322.0 |
uEq/100g/6 hrs |
28.58 |
70.0 |
automated urine analysis |
|
|
0 |
|
|
95539 |
1662 |
WKY/Izm |
mean arterial blood pressure |
control condition |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
arterial blood pressure trait |
male |
98 days
| 6 |
|
107.0 |
mmHg |
4.0 |
9.8 |
vascular indwelling catheter method |
|
0.0 |
0 |
|
|
84547 |
1120 |
WKY/Izm |
systolic blood pressure |
specific pathogen-free condition |
NBRP Blood Pressure and Heart Rate data |
arterial blood pressure trait |
male |
56 days-70 days |
6 |
serial mean |
113.0 |
mmHg |
4.49 |
11.0 |
tail cuff photoplethysmography |
|
|
0 |
NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan |
|
75186 |
14 |
WKY/Izm |
heart rate |
specific pathogen-free condition |
NBRP Blood Pressure and Heart Rate data |
heart pumping trait |
male |
56 days-70 days |
6 |
serial mean |
433.0 |
beats/min |
9.8 |
24.0 |
tail cuff photoplethysmography |
|
|
0 |
NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan |
|
75187 |
14 |
WKY/Izm |
serum total cholesterol level |
control condition |
Kato N, et al., Arterioscler Thromb Vasc Biol 2000 Jan;20(1):223-9 |
blood cholesterol amount |
male |
112 days
| 5 |
|
72.54 |
mg/dl |
1.54 |
3.45 |
serum total cholesterol measurement test |
|
0.0 |
0 |
|
some flavor of WKY |
68957 |
1033 |
WKY/Izm |
prothrombin time |
fasting (for 16 hours) |
NBRP Hematology & Blood Biochemistry data |
blood coagulation trait |
male |
70 days
| 6 |
|
16.1 |
s |
0.16 |
0.4 |
automated coagulometer method |
|
|
0 |
Sysmex, CA-3000 type |
|
79844 |
1498 |
WKY/Izm |
plasma glucose level |
fasting (for 16 hours) |
NBRP Hematology & Blood Biochemistry data |
blood glucose amount |
male |
70 days
| 6 |
|
129.0 |
mg/dl |
2.86 |
7.0 |
automated plasma analysis |
|
|
0 |
PMID:15591307 |
|
79852 |
1498 |
WKY/Izm |
blood band neutrophil count to total leukocyte count ratio |
fasting (for 16 hours) |
NBRP Hematology & Blood Biochemistry data |
neutrophil quantity |
male |
70 days
| 6 |
|
0.0 |
% |
0.0 |
0.0 |
automated differential white blood cell count test |
|
|
0 |
May-Giemsa staining |
band neutrophil % |
79865 |
1498 |
WKY/Izm |
plasma glucose level |
fasting (0 null) (for 16 hours) |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
blood glucose amount |
male |
91 days
| 5 |
|
147.06 |
mg/dl |
5.76 |
12.88 |
blood glucose analysis |
|
0 |
0 |
|
|
64870 |
115 |
WKY/Izm |
lung weight to body weight ratio |
specific pathogen-free condition |
NBRP Organ Weight data |
lung mass |
male |
70 days
| 6 |
|
0.41 |
% |
0.01 |
0.02 |
Shimadzu electronic balance post excision weight measurement |
|
|
0 |
|
|
72878 |
41 |
WKY/Izm |
both adrenal glands weight to body weight ratio |
specific pathogen-free condition |
NBRP Organ Weight data |
adrenal gland mass |
male |
70 days
| 6 |
|
21.4 |
mg/100g |
0.57 |
1.4 |
Shimadzu electronic balance post excision weight measurement |
|
|
0 |
|
|
72884 |
41 |
WKY/Izm |
spleen weight to body weight ratio |
specific pathogen-free condition |
NBRP Organ Weight data |
spleen mass |
male |
70 days
| 6 |
|
0.17 |
% |
0.0 |
0.01 |
Shimadzu electronic balance post excision weight measurement |
|
|
0 |
|
|
72886 |
41 |
WKY/Izm |
systolic blood pressure |
controlled fat content diet (5 %) (for 63 days) and controlled potassium content diet (0.75 %) |
Watanabe T, et al., Biochem Biophys Res Commun 2005 Apr 15;329(3):879-87. |
arterial blood pressure trait |
male |
91 days
| 10 |
|
132.2 |
mmHg |
2.18 |
6.9 |
tail cuff plethysmography |
|
|
0 |
|
|
13277 |
263 |
WKY/Izm |
epididymal fat pad weight to body weight ratio |
control condition |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
epididymal fat pad mass |
male |
91 days
| 5 |
|
1.34 |
% |
0.03 |
0.07 |
post excision weight measurement |
testis |
0 |
0 |
|
|
65000 |
115 |
WKY/Izm |
body weight |
control condition (0 null) |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
body mass |
female |
91 days
| 5 |
|
200.8 |
g |
3.1 |
6.93 |
body weighing method |
|
0 |
0 |
|
|
64833 |
115 |
WKY/Izm |
urine norepinephrine excretion rate |
room temperature (for 4 hours) then cold ambient air exposure (4 degrees C) (for 4 hours) |
Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. |
urine norepinephrine amount |
not specified |
0 days
| 14 |
|
1890.0 |
pmol/4h |
227.17 |
850.0 |
high-performance liquid chromatography |
|
0.0 |
0 |
hplc |
absolute change in urine norepinephrine excretion rate |
68660 |
971 |
WKY/Izm |
serum total cholesterol level |
control condition |
Kato N, et al., Arterioscler Thromb Vasc Biol 2000 Jan;20(1):223-9 |
blood cholesterol amount |
female |
112 days
| 5 |
|
80.6 |
mg/dl |
2.45 |
5.48 |
serum total cholesterol measurement test |
|
0.0 |
0 |
|
some flavor of WKY |
68958 |
1033 |
WKY/Izm |
absolute change in plasma epinephrine level |
room temperature (for 4 hours) then cold ambient air exposure (4 degrees C) (for 4 hours) |
Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. |
blood epinephrine amount |
not specified |
0 days
| 5 |
|
0.68 |
pmol/l |
0.62 |
1.38 |
high-performance liquid chromatography |
|
0.0 |
0 |
hplc |
difference in plasma epinephrine between base and 4 degrees |
68674 |
971 |
WKY/Izm |
adipocyte basal glucose uptake |
controlled fat content diet (5 %) (for 70 days) and controlled potassium content diet (0.75 %) (for 70 days) |
Watanabe T, et al., Biochem Biophys Res Commun 2005 Apr 15;329(3):879-87. |
adipocyte glucose uptake trait |
male |
105 days
| 10 |
|
37.9 |
x 1000 cpm/cell |
1.52 |
4.8 |
radioactive glucose uptake assay with liquid scintillation counting |
|
0.0 |
0 |
|
|
67926 |
263 |
WKY/Izm |
absolute change in heart rate |
room temperature (for 0.5 hours) then cold ambient air exposure (4 degrees C) (for 4 hours) |
Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. |
heart pumping trait |
not specified |
84 days-112 days |
5 |
serial mean |
221.0 |
beats/min |
6.71 |
15.0 |
radiotelemetry |
|
16200.0 |
0 |
10 s every 5 min |
|
68686 |
971 |
WKY/Izm |
absolute change in heart rate |
room temperature (for 0.5 hours) then cold ambient air exposure (4 degrees C) (for 4 hours) |
Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. |
heart pumping trait |
not specified |
84 days-112 days |
6 |
serial mean |
107.0 |
beats/min |
6.12 |
15.0 |
radiotelemetry |
|
16200.0 |
0 |
10 s every 5 min |
|
68689 |
971 |
WKY/Izm |
absolute change in urine norepinephrine level |
cold ambient air exposure (4 degrees C) (for 6 hours) |
Xiao B, et al., J Hypertens. 2010 Nov 8. |
urine norepinephrine amount |
male |
84 days
| 16 |
|
28.83 |
nmol/h |
|
|
high-performance liquid chromatography |
|
0.0 |
0 |
|
nmol/6h |
84608 |
990 |
WKY/Izm |
hematocrit |
fasting (for 16 hours) |
NBRP Hematology & Blood Biochemistry data |
erythrocyte quantity |
male |
70 days
| 6 |
|
47.2 |
% |
0.73 |
1.8 |
automated cell/particle size/count analysis method |
|
|
0 |
Sysmex, F-800 type |
|
79838 |
1498 |
WKY/Izm |
platelet count |
fasting (for 16 hours) |
NBRP Hematology & Blood Biochemistry data |
platelet quantity |
male |
70 days
| 6 |
|
863.0 |
x 1000 /ul |
9.8 |
24.0 |
automated cell/particle size/count analysis method |
|
|
0 |
Sysmex, F-800 type |
|
79843 |
1498 |
WKY/Izm |
plasma albumin level |
fasting (for 16 hours) |
NBRP Hematology & Blood Biochemistry data |
blood albumin amount |
male |
70 days
| 6 |
|
0.38 |
g/l |
0.0 |
0.01 |
automated plasma albumin analysis |
|
|
0 |
Hitachi, model 7170 |
|
79850 |
1498 |
WKY/Izm |
plasma albumin to plasma total protein ratio |
fasting (for 16 hours) |
NBRP Hematology & Blood Biochemistry data |
blood albumin amount |
male |
70 days
| 6 |
|
1.66 |
null |
0.02 |
0.04 |
automated plasma protein analysis |
|
|
0 |
Hitachi, model 7170 |
plasma albumin to plasma total protein ratio |
79851 |
1498 |
WKY/Izm |
plasma triglyceride level |
fasting (for 16 hours) |
NBRP Hematology & Blood Biochemistry data |
blood triglyceride amount |
male |
70 days
| 6 |
|
0.35 |
mmol/l |
0.04 |
0.09 |
automated plasma analysis |
|
|
0 |
PMID:15591307 |
|
79854 |
1498 |
WKY/Izm |
blood eosinophil count to total leukocyte count ratio |
fasting (for 16 hours) |
NBRP Hematology & Blood Biochemistry data |
eosinophil quantity |
male |
70 days
| 6 |
|
1.0 |
% |
0.41 |
1.0 |
automated differential white blood cell count test |
|
|
0 |
May-Giemsa staining |
|
79864 |
1498 |
WKY/Izm |
blood segmented neutrophil count to total leukocyte count ratio |
fasting (for 16 hours) |
NBRP Hematology & Blood Biochemistry data |
neutrophil quantity |
male |
70 days
| 6 |
|
19.0 |
% |
1.63 |
4.0 |
automated differential white blood cell count test |
|
|
0 |
May-Giemsa staining |
segmented neutrophil % |
79866 |
1498 |
WKY/Izm |
blood lymphocyte count to total leukocyte count ratio |
fasting (for 16 hours) |
NBRP Hematology & Blood Biochemistry data |
lymphocyte quantity |
male |
70 days
| 6 |
|
80.0 |
% |
1.63 |
4.0 |
automated differential white blood cell count test |
|
|
0 |
May-Giemsa staining |
|
79867 |
1498 |
WKY/Izm |
timed urine volume |
0.9% sodium chloride solution (25 ml/kg) |
NBRP Urine Volume and Urine Electrolyte data |
urine output |
male |
63 days
| 6 |
|
24.36 |
ml/d |
1.85 |
4.52 |
metabolic cage urine volume measurement method |
|
|
0 |
|
|
95532 |
1662 |
WKY/Izm |
timed urine volume to body weight ratio |
0.9% sodium chloride solution (25 ml/kg) |
NBRP Urine Volume and Urine Electrolyte data |
urine output |
male |
63 days
| 6 |
|
0.06 |
ul/min/g |
0.0 |
0.01 |
metabolic cage urine volume measurement method |
|
|
0 |
|
|
95533 |
1662 |
WKY/Izm |
urine sodium level |
0.9% sodium chloride solution (25 ml/kg) |
NBRP Urine Volume and Urine Electrolyte data |
urine sodium amount |
male |
63 days
| 6 |
|
109.5 |
mmol/l |
8.65 |
21.2 |
automated urine analysis |
|
|
0 |
Analytical intruments, PVA alpha II |
|
95534 |
1662 |
WKY/Izm |
urine potassium level |
0.9% sodium chloride solution (25 ml/kg) |
NBRP Urine Volume and Urine Electrolyte data |
urine potassium amount |
male |
63 days
| 6 |
|
84.6 |
mmol/l |
3.67 |
9.0 |
automated urine analysis |
|
|
0 |
Analytical intruments, PVA alpha II |
|
95536 |
1662 |
WKY/Izm |
absolute change in heart rate |
air-jet exposure (for 0 hours) then candesartan (1 ug) (for 0 hours) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
heart pumping trait |
male |
98 days
| 6 |
|
-5.0 |
beats/min |
11.0 |
26.94 |
vascular indwelling catheter method |
|
0.0 |
0 |
|
|
84563 |
1120 |
WKY/Izm |
systolic blood pressure |
controlled visible light exposure |
Xiao B, et al., J Hypertens. 2010 Nov 8. |
arterial blood pressure trait |
male |
94 days
| 0 |
serial mean |
112.0 |
mmHg |
|
10.0 |
radiotelemetry |
|
0.0 |
0 |
|
avg of 5 measurements for |
84612 |
990 |
WKY/Izm |
spleen wet weight |
specific pathogen-free condition |
NBRP Organ Weight data |
spleen mass |
male |
70 days
| 6 |
|
0.45 |
g |
0.01 |
0.01 |
Shimadzu electronic balance post excision weight measurement |
|
|
0 |
|
|
72885 |
41 |
WKY/Izm |
serum total cholesterol level |
controlled fat content diet (5 %) (for 70 days) and controlled potassium content diet (for 70 days) then fasting |
Watanabe T, et al., Biochem Biophys Res Commun 2005 Apr 15;329(3):879-87. |
blood cholesterol amount |
male |
98 days
| 10 |
|
73.3 |
mg/dl |
2.34 |
7.4 |
serum total cholesterol measurement test |
|
|
0 |
|
|
12495 |
263 |
WKY/Izm |
body weight |
specific pathogen-free condition |
NBRP Body Weight data |
body mass |
male |
42 days
| 6 |
|
151.4 |
g |
2.16 |
5.3 |
whole body digital scale |
|
|
0 |
|
|
70933 |
21 |
WKY/Izm |
plasma alanine aminotransferase activity level |
fasting (for 16 hours) |
NBRP Hematology & Blood Biochemistry data |
blood alanine transaminase amount |
male |
70 days
| 6 |
|
26.0 |
U/l |
0.41 |
1.0 |
automated plasma analysis |
|
|
0 |
PMID:15591307 |
|
79847 |
1498 |
WKY/Izm |
plasma total protein level |
fasting (for 16 hours) |
NBRP Hematology & Blood Biochemistry data |
blood total protein amount |
male |
70 days
| 6 |
|
60.0 |
mg/ml |
0.82 |
2.0 |
automated plasma total protein analysis |
|
|
0 |
Hitachi, model 7170 |
|
79849 |
1498 |
WKY/Izm |
plasma total bilirubin level |
fasting (for 16 hours) |
NBRP Hematology & Blood Biochemistry data |
blood bilirubin amount |
male |
70 days
| 6 |
|
0.05 |
mg/dl |
0.0 |
0.01 |
automated plasma analysis |
|
|
0 |
PMID:15591307 |
total plasma bilirubin level |
79855 |
1498 |
WKY/Izm |
plasma sodium level |
fasting (for 16 hours) |
NBRP Hematology & Blood Biochemistry data |
blood sodium amount |
male |
70 days
| 6 |
|
145.6 |
mmol/l |
0.33 |
0.8 |
automated blood electrolyte analysis |
|
|
0 |
Analytical intruments, PVA alpha II |
|
79860 |
1498 |
WKY/Izm |
plasma glucose level |
fasting (0 null) (for 16 hours) |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
blood glucose amount |
female |
91 days
| 5 |
|
207.18 |
mg/dl |
10.44 |
23.34 |
blood glucose analysis |
|
0 |
0 |
|
|
64875 |
115 |
WKY/Izm |
serum free fatty acids level |
fasting (0 null) (for 16 hours) |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
blood free fatty acid amount |
male |
91 days
| 5 |
|
0.39 |
mmol/l |
0.02 |
0.04 |
serum free fatty acid analysis |
|
0 |
0 |
|
|
64864 |
115 |
WKY/Izm |
heart weight to body weight ratio |
specific pathogen-free condition |
NBRP Organ Weight data |
heart mass |
male |
70 days
| 6 |
|
3.54 |
g/kg |
0.04 |
0.09 |
Shimadzu electronic balance post excision weight measurement |
|
|
0 |
|
|
72876 |
41 |
WKY/Izm |
both kidneys wet weight |
specific pathogen-free condition |
NBRP Organ Weight data |
kidney mass |
male |
70 days
| 6 |
|
1.8 |
g |
0.03 |
0.07 |
Shimadzu electronic balance post excision weight measurement |
|
|
0 |
|
|
72881 |
41 |
WKY/Izm |
heart rate |
control condition |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
heart pumping trait |
male |
98 days
| 6 |
|
320.0 |
beats/min |
11.0 |
26.94 |
vascular indwelling catheter method |
|
0.0 |
0 |
|
|
84550 |
1120 |
WKY/Izm |
serum triglyceride level |
fasting (0 null) (for 16 hours) |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
blood triglyceride amount |
female |
91 days
| 5 |
|
40.71 |
mg/dl |
7.96 |
17.81 |
serum triglyceride analysis |
|
0 |
0 |
|
|
64861 |
115 |
WKY/Izm |
heart weight to body weight ratio |
control condition (0 null) |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
heart mass |
male |
91 days
| 5 |
|
2.47 |
g/kg |
0.09 |
0.2 |
post excision weight measurement |
|
0 |
0 |
|
|
64837 |
115 |
WKY/Izm |
urine norepinephrine excretion rate |
cold ambient air exposure (4 degrees C) (for 4 hours) |
Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. |
urine norepinephrine amount |
not specified |
0 days
| 14 |
|
2670.0 |
pmol/4h |
171.05 |
640.0 |
high-performance liquid chromatography |
|
0.0 |
0 |
hplc |
urine norepinephrine excretion rate |
68657 |
971 |
WKY/Izm |
absolute change in plasma norepinephrine level |
room temperature (for 4 hours) then cold ambient air exposure (4 degrees C) (for 4 hours) |
Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. |
blood norepinephrine amount |
not specified |
0 days
| 5 |
|
3.92 |
pmol/l |
1.01 |
2.26 |
high-performance liquid chromatography |
|
0.0 |
0 |
hplc |
difference in plasma norepinephrine between base and 4 degrees |
68672 |
971 |
WKY/Izm |
serum free fatty acids level |
controlled fat content diet (5 %) (for 70 days) and controlled potassium content diet (0.75 %) (for 70 days) then controlled fat content diet (26 %) (for 14 days) and controlled potassium content diet (0.44 %) (for 14 days) then fasting (for 16 hours) |
Watanabe T, et al., Biochem Biophys Res Commun 2005 Apr 15;329(3):879-87. |
blood free fatty acid amount |
male |
113 days
| 10 |
|
0.03 |
mmol/l |
0.0 |
0.01 |
serum free fatty acid analysis |
|
0.0 |
0 |
|
|
67924 |
263 |
WKY/Izm |
absolute change in systolic blood pressure |
cold ambient air exposure (4 degrees C) (for 3 hours) |
Xiao B, et al., J Hypertens. 2010 Nov 8. |
arterial blood pressure trait |
male |
94 days
| 6 |
serial mean |
17.0 |
mmHg |
|
|
radiotelemetry |
|
0.0 |
0 |
|
avg of 5 measurements for |
84611 |
990 |
WKY/Izm |
plasma aspartate aminotransferase activity level |
fasting (for 16 hours) |
NBRP Hematology & Blood Biochemistry data |
blood aspartate transaminase amount |
male |
70 days
| 6 |
|
81.0 |
U/l |
1.63 |
4.0 |
automated plasma analysis |
|
|
0 |
PMID:15591307 |
|
79846 |
1498 |
WKY/Izm |
plasma alkaline phosphatase activity level |
fasting (for 16 hours) |
NBRP Hematology & Blood Biochemistry data |
blood alkaline phosphatase amount |
male |
70 days
| 6 |
|
377.0 |
IU/l |
8.98 |
22.0 |
automated plasma analysis |
|
|
0 |
PMID:15591307 |
|
79848 |
1498 |
WKY/Izm |
plasma total cholesterol level |
fasting (for 16 hours) |
NBRP Hematology & Blood Biochemistry data |
blood cholesterol amount |
male |
70 days
| 6 |
|
95.0 |
mg/dl |
2.45 |
6.0 |
automated plasma analysis |
|
|
0 |
PMID:15591307 |
|
79853 |
1498 |
WKY/Izm |
plasma phosphate level |
fasting (for 16 hours) |
NBRP Hematology & Blood Biochemistry data |
blood phosphate amount |
male |
70 days
| 6 |
|
7.4 |
mg/dl |
0.08 |
0.2 |
automated blood electrolyte analysis |
|
|
0 |
Hitachi, model 7170 |
|
79858 |
1498 |
WKY/Izm |
plasma potassium level |
fasting (for 16 hours) |
NBRP Hematology & Blood Biochemistry data |
blood potassium amount |
male |
70 days
| 6 |
|
4.33 |
mmol/l |
0.1 |
0.25 |
automated blood electrolyte analysis |
|
|
0 |
Analytical intruments, PVA alpha II |
|
79861 |
1498 |
WKY/Izm |
stimulated renal sympathetic nerve activity to basal renal sympathetic nerve activity ratio |
air-jet exposure (for 0 hours) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
kidney sympathetic nerve activity |
male |
98 days
| 6 |
|
78.0 |
% |
20.0 |
48.99 |
implanted wire electrode recording method |
|
0.0 |
0 |
|
percent change rsna |
84539 |
1120 |
WKY/Izm |
urine sodium excretion rate to body weight ratio |
0.9% sodium chloride solution (25 ml/kg) |
NBRP Urine Volume and Urine Electrolyte data |
urine sodium amount |
male |
63 days
| 6 |
|
0.01 |
uEq/min/g |
0.0 |
0.0 |
automated urine analysis |
|
|
0 |
Analytical intruments, PVA alpha II |
|
95535 |
1662 |
WKY/Izm |
urine potassium excretion rate to body weight ratio |
0.9% sodium chloride solution (25 ml/kg) |
NBRP Urine Volume and Urine Electrolyte data |
urine potassium amount |
male |
63 days
| 6 |
|
179.0 |
uEq/100g/6 hrs |
11.43 |
28.0 |
automated urine analysis |
|
|
0 |
Analytical intruments, PVA alpha II |
|
95537 |
1662 |
WKY/Izm |
absolute change in mean arterial blood pressure |
candesartan (1 ug) (for 0 hours) then air-jet exposure (for 0 hours) then angiotensin II (20 ng) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
arterial blood pressure trait |
male |
98 days
| 6 |
|
0.0 |
mmHg |
1.0 |
2.45 |
vascular indwelling catheter method |
|
0.0 |
0 |
|
|
84567 |
1120 |
WKY/Izm |
absolute change in mean arterial blood pressure |
air-jet exposure (for 0 hours) then candesartan (1 ug) (for 0 hours) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
arterial blood pressure trait |
male |
98 days
| 6 |
|
-3.0 |
mmHg |
1.0 |
2.45 |
vascular indwelling catheter method |
|
0.0 |
0 |
|
|
84545 |
1120 |
WKY/Izm |
absolute change in mean arterial blood pressure |
air-jet exposure (for 0 hours) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
arterial blood pressure trait |
male |
98 days
| 6 |
|
23.0 |
mmHg |
2.0 |
4.9 |
vascular indwelling catheter method |
|
0.0 |
0 |
|
|
84556 |
1120 |
WKY/Izm |
systolic blood pressure |
controlled exposure to darkness |
Xiao B, et al., J Hypertens. 2010 Nov 8. |
arterial blood pressure trait |
male |
94 days
| 0 |
serial mean |
120.0 |
mmHg |
|
17.0 |
radiotelemetry |
|
0.0 |
0 |
|
avg of 5 measurements for |
84614 |
990 |
WKY/Izm |
body temperature |
specific pathogen-free condition |
NBRP Body Temperature data |
body temperature trait |
male |
56 days-70 days |
6 |
serial mean |
38.0 |
degrees C |
0.2 |
0.5 |
digital rectal thermometry |
|
|
0 |
|
|
75188 |
22 |
WKY/Izm |
brain weight to body weight ratio |
specific pathogen-free condition |
NBRP Organ Weight data |
brain mass |
male |
70 days
| 6 |
|
0.8 |
% |
0.01 |
0.03 |
Shimadzu electronic balance post excision weight measurement |
|
|
0 |
|
|
72874 |
41 |
WKY/Izm |
liver wet weight |
specific pathogen-free condition |
NBRP Organ Weight data |
liver mass |
male |
70 days
| 6 |
|
7.16 |
g |
0.17 |
0.42 |
Shimadzu electronic balance post excision weight measurement |
|
|
0 |
|
|
72879 |
41 |
WKY/Izm |
liver weight as percentage of body weight |
specific pathogen-free condition |
NBRP Organ Weight data |
liver mass |
male |
70 days
| 6 |
|
2.67 |
% |
0.04 |
0.09 |
Shimadzu electronic balance post excision weight measurement |
|
|
0 |
|
|
72880 |
41 |
WKY/Izm |
both testes wet weight to body weight ratio |
specific pathogen-free condition |
NBRP Organ Weight data |
testis mass |
male |
70 days
| 6 |
|
1.08 |
% |
0.01 |
0.03 |
Shimadzu electronic balance post excision weight measurement |
|
|
0 |
|
|
72888 |
41 |
WKY/Izm |
red blood cell count |
fasting (for 16 hours) |
NBRP Hematology & Blood Biochemistry data |
erythrocyte quantity |
male |
70 days
| 6 |
|
8.37 |
x 10E6 cells/ul |
0.11 |
0.28 |
automated cell/particle size/count analysis method |
|
|
0 |
Sysmex, F-800 type |
|
79836 |
1498 |
WKY/Izm |
absolute change in mean arterial blood pressure |
air-jet exposure (for 0 hours) then candesartan (1 ug) (for 0 hours) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
arterial blood pressure trait |
male |
98 days
| 6 |
|
0.0 |
mmHg |
2.0 |
4.9 |
vascular indwelling catheter method |
|
0.0 |
0 |
|
|
84552 |
1120 |